These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 19769734)
21. Potential role of dendritic cell vaccination with MAGE peptides in gastrointestinal carcinomas. Tanaka F; Haraguchi N; Isikawa K; Inoue H; Mori M Oncol Rep; 2008 Nov; 20(5):1111-6. PubMed ID: 18949409 [TBL] [Abstract][Full Text] [Related]
22. Delivery of tumor-antigen-encoding mRNA into dendritic cells for vaccination. Michiels A; Tuyaerts S; Bonehill A; Heirman C; Corthals J; Thielemans K Methods Mol Biol; 2008; 423():155-63. PubMed ID: 18370196 [TBL] [Abstract][Full Text] [Related]
23. [Methods for increasing the immunogenicity of vaccines]. Kündig TM Praxis (Bern 1994); 2000 Sep; 89(37):1477-84. PubMed ID: 11037620 [TBL] [Abstract][Full Text] [Related]
24. [New therapeutic approachs in melanoma]. Mortier L; Marchetti P; Gordower L; Charbonnier-Hatzfeld AS; Toungouz M; Velu T Rev Med Brux; 2004 Jun; 25(3):153-9. PubMed ID: 15291447 [TBL] [Abstract][Full Text] [Related]
25. Dendritic cell immunotherapy for stage IV melanoma. O'Rourke MG; Johnson MK; Lanagan CM; See JL; O'Connor LE; Slater GJ; Thomas D; Lopez JA; Martinez NR; Ellem KA; Schmidt CW Melanoma Res; 2007 Oct; 17(5):316-22. PubMed ID: 17885587 [TBL] [Abstract][Full Text] [Related]
26. Vaccination: role in metastatic melanoma. Pilla L; Valenti R; Marrari A; Patuzzo R; Santinami M; Parmiani G; Rivoltini L Expert Rev Anticancer Ther; 2006 Aug; 6(8):1305-18. PubMed ID: 16925496 [TBL] [Abstract][Full Text] [Related]
27. Dendritic cells and antigen trapping technology--a revolution in vaccine/immunotherapy strategy. Pal C; Ganguly D; Paul K; Pal S Indian J Exp Biol; 2007 Jun; 45(6):491-504. PubMed ID: 17585683 [TBL] [Abstract][Full Text] [Related]
28. Dendritic cell-based cancer vaccination: quo vadis? Dauer M; Schnurr M; Eigler A Expert Rev Vaccines; 2008 Sep; 7(7):1041-53. PubMed ID: 18767953 [TBL] [Abstract][Full Text] [Related]
29. The treatment of melanoma with an emphasis on immunotherapeutic strategies. Jack A; Boyes C; Aydin N; Alam K; Wallack M Surg Oncol; 2006 Jul; 15(1):13-24. PubMed ID: 16815006 [TBL] [Abstract][Full Text] [Related]
30. Cell fusion: from hybridoma to dendritic cell-based vaccine. Gong J; Koido S; Calderwood SK Expert Rev Vaccines; 2008 Sep; 7(7):1055-68. PubMed ID: 18767954 [TBL] [Abstract][Full Text] [Related]
31. Targets of protective tumor immunity. Dranoff G Ann N Y Acad Sci; 2009 Sep; 1174():74-80. PubMed ID: 19769739 [TBL] [Abstract][Full Text] [Related]
32. Vaccines and melanoma. Ott PA; Fritsch EF; Wu CJ; Dranoff G Hematol Oncol Clin North Am; 2014 Jun; 28(3):559-69. PubMed ID: 24880947 [TBL] [Abstract][Full Text] [Related]
33. Sustained and NK/CD4+ T cell-dependent efficient prevention of lung metastasis induced by dendritic cells harboring recombinant Sendai virus. Komaru A; Ueda Y; Furuya A; Tanaka S; Yoshida K; Kato T; Kinoh H; Harada Y; Suzuki H; Inoue M; Hasegawa M; Ichikawa T; Yonemitsu Y J Immunol; 2009 Oct; 183(7):4211-9. PubMed ID: 19734206 [TBL] [Abstract][Full Text] [Related]
34. Experimental frontiers for clinical applications: novel approaches to understanding mechanisms of lymph node metastases in melanoma. Essner R Cancer Metastasis Rev; 2006 Jun; 25(2):257-67. PubMed ID: 16770538 [TBL] [Abstract][Full Text] [Related]
35. Vaccine therapy for melanoma: current status and future directions. Terando AM; Faries MB; Morton DL Vaccine; 2007 Sep; 25 Suppl 2():B4-16. PubMed ID: 17646038 [TBL] [Abstract][Full Text] [Related]
36. [Changes of dendritic cells in prostate cancer and dendritic cell-based immunotherapy]. Qi SY; Wang M; Xu Y Zhonghua Nan Ke Xue; 2007 May; 13(5):453-6. PubMed ID: 17569266 [TBL] [Abstract][Full Text] [Related]
37. Immunologic approaches to the management of pancreatic cancer. Laheru D; Biedrzycki B; Jaffee EM Cancer J; 2001; 7(4):324-37. PubMed ID: 11561608 [TBL] [Abstract][Full Text] [Related]
38. [State of the art about new therapeutic vaccines in prostate cancer: dendritic cells, engineered tumor cells and recombinant virus]. Eymard JC; Gervais A; Jarcau R; Bernard J Bull Cancer; 2007 Jul; 94(7 Suppl):F69-76. PubMed ID: 17845996 [TBL] [Abstract][Full Text] [Related]